Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,692.00
Bid: 2,686.00
Ask: 2,688.00
Change: -14.00 (-0.52%)
Spread: 2.00 (0.074%)
Open: 2,708.00
High: 2,708.00
Low: 2,670.00
Prev. Close: 2,706.00
CCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

12 Oct 2020 12:44

RNS Number : 8122B
Coca-Cola HBC AG
12 October 2020
 

 

 

 

Coca-Cola HBC AG

Conference call invitation for investors and analysts

2020 third quarter trading update on Wednesday, 11 November 2020

 

 

Zug, Switzerland - 12 October 2020 - Coca-Cola HBC AG (Coca‑Cola HBC) will release their 2020 third quarter trading update results on Wednesday, 11 November 2020 at 7:00 am GMT. The press release will be available as of that time on the company website: https://www.coca-colahellenic.com/

 

Coca-Cola HBC's management will host a conference call for investors and analysts on Wednesday, 11 November 2020 at 9:00 am GMT.

 

To join the call in listen-only mode please join via webcast at:  https://www.coca-colahellenic.com/en/investors-and-financial/results-reports-presentations

 

If you anticipate asking a question, please dial one of the following numbers and quote 'Coca‑Cola Hellenic'. Please dial in 20 minutes early to allow the operator to manage demand in the current environment and to ensure that you are able to join the call at the start.

 

UK participants - toll free

0808 109 0700

US participants - toll free

1 866 966 5335

Greek participants - toll free

00800 1273 78

Swiss participants - toll free

0800 800 038

Standard international

+44 (0) 20 3003 2666

 

The conference call, which will include management's remarks followed by a question and answer session, will last approximately one hour.

 

A recording of the call and its transcript will be made available on the Company's website following the conference call: https://www.coca-colahellenic.com/en/investors-and-financial/results-reports-presentations

 

 

 

Enquiries

Coca‑Cola HBC Group

Investors and Analysts:

Joanna Kennedy

Investor Relations Director

Tel: +44 20 37 444 230

 joanna.kennedy@cchellenic.com

Carla Fabiano

Investor Relations Manager

Tel: +44 20 37 444 231

carla.fabiano@cchellenic.com

Media:

David Hart

Group Communication Director

Tel: +41 41 726 0143

 david.hart@cchellenic.com

 

Greek media contact:

V+O Communications

Argyro Oikonomou

Tel: +30 211 7501219

ao@vando.gr

 

 

 

 

About Coca‑Cola HBC

Coca-Cola HBC is a growth-focused CPG business and strategic bottling partner of The Coca-Cola Company. We create value for all our stakeholders by supporting the socio-economic development of the societies in which we operate and we believe building a more positive environmental impact is integral to our future growth. Together, we and our customers serve more than 600 million consumers across a broad geographic footprint of 28 countries on 3 continents. Our portfolio is one of the strongest, broadest and most flexible in the beverage industry, offering consumer-leading partner brands in the sparkling, juice, water, sport, energy, plant-based, ready-to-drink tea, coffee, adult sparkling and premium spirits categories. These brands include Coca-Cola, Coca-Cola Zero, Schweppes, Kinley, Royal Bliss, Costa Coffee, Valser, Romerquelle, Fanta, Sprite, Powerade, FuzeTea, Dobry, Cappy, Monster and Adez. We foster an open and inclusive work environment amongst our more than 28,000 employees and we are ranked among the top sustainability performers in ESG benchmarks such as the Dow Jones Sustainability Indices, CDP, MSCI ESG and FTSE4Good.

Coca-Cola HBC has a premium listing on the London Stock Exchange (LSE:CCH) and is listed on the Athens Exchange (ATHEX:EEE). For more information, please visit http://www.coca-colahellenic.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORFFDFFEESSELS
Date   Source Headline
21st Feb 201810:21 amRNSDirector/PDMR Shareholding
21st Feb 201810:13 amRNSDirector/PDMR Shareholding
20th Feb 20182:16 pmRNSDirector/PDMR Shareholding
20th Feb 20181:31 pmRNSDirector/PDMR Shareholding
20th Feb 20181:19 pmRNSDirector/PDMR Shareholding
20th Feb 20181:00 pmRNSDirector/PDMR Shareholding
16th Feb 201811:22 amRNSDirector/PDMR Shareholding
14th Feb 20187:00 amRNSEXCEPTIONAL SET OF RESULTS
1st Feb 201810:35 amRNSIssue of equity and total voting rights
19th Jan 20184:02 pmRNSDirector/PDMR Shareholding
17th Jan 201811:05 amRNSNotice of Results
5th Jan 20184:02 pmRNSAthens Exchange trading date of ordinary shares
2nd Jan 201810:04 amRNSIssue of equity and total voting rights
20th Dec 20172:15 pmRNSDirector/PDMR Shareholding
7th Dec 20177:00 amRNSAppointment of Chief Executive Officer
1st Dec 20179:06 amRNSIssue of Equity and Total Voting Rights
20th Nov 201711:57 amRNSDirector/PDMR Shareholding
9th Nov 20177:00 amRNSCONTINUING TO DELIVER EXCELLENT REVENUE GROWTH
1st Nov 20179:07 amRNSIssue of Equity and Total Voting Rights
1st Nov 20178:55 amRNSBlock listing Interim Review
18th Oct 201712:55 pmRNSDirector/PDMR Shareholding
9th Oct 201711:45 amRNSNotice of Results
3rd Oct 20177:00 amRNSStatement re. Chief Executive Officer
2nd Oct 20179:27 amRNSIssue of Equity and Total Voting Rights
27th Sep 201711:13 amRNSDirector Declaration
19th Sep 20173:30 pmRNSDirector/PDMR Shareholding
15th Sep 20177:01 amRNSCEO's medical leave of absence
1st Sep 20179:30 amRNSIssue of Equity and Total Voting Rights
21st Aug 201711:37 amRNSDirector/PDMR Shareholding
10th Aug 20177:00 amRNSEXCELLENT FIRST HALF RESULTS
1st Aug 20179:35 amRNSIssue of Equity and Total Voting Rights
28th Jul 20171:02 pmRNSDirector/PDMR Shareholding
19th Jul 20171:51 pmRNSDirector/PDMR Shareholding
4th Jul 201712:56 pmRNSNotice of Results
3rd Jul 20178:16 amRNSIssue of Equity and Total Voting Rights
21st Jun 20179:26 amRNSDirectorate Change
21st Jun 20179:15 amRNSResult of AGM
20th Jun 20173:00 pmRNSDirector/PDMR Shareholding
2nd Jun 201711:42 amRNSAthens Exchange trading date of ordinary shares
1st Jun 20177:54 amRNSIssue of Equity and Total Voting Rights
19th May 201712:24 pmRNSDirector/PDMR Shareholding
16th May 20177:11 amRNSNotice of AGM
15th May 20177:23 amRNSchange to the Board and confirms dividend dates
11th May 20177:00 amRNSYEAR STARTS WELL WITH GOOD REVENUE GROWTH
2nd May 20179:07 amRNSIssue of Equity and Total Voting Rights
2nd May 20178:48 amRNSBlock listing Interim Review
28th Apr 20174:53 pmRNSCoca-Cola HBC Finance B.V. - Annual Report 2016
19th Apr 20174:24 pmRNSDirector/PDMR Shareholding
10th Apr 20173:07 pmRNSNotice of Results
3rd Apr 20178:14 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.